<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Global postoperative <z:e sem="disease" ids="C0002622" disease_type="Mental or Behavioral Dysfunction" abbrv="">amnesia</z:e> (profound anterograde and <z:e sem="disease" ids="C0002624" disease_type="Mental or Behavioral Dysfunction" abbrv="">retrograde amnesia</z:e>) is rare and usually attributed to <z:hpo ids='HP_0010534'>transient global amnesia</z:hpo>-a poorly understood condition with no broadly accepted mechanism </plain></SENT>
<SENT sid="1" pm="."><plain>We report an incident of probable <z:hpo ids='HP_0010534'>transient global amnesia</z:hpo> in a patient after endoscopic retrograde cholangiopancreatogram under general anesthesia, which was successfully treated with <z:chebi fb="0" ids="5103">flumazenil</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>On the basis of the results of <z:chebi fb="0" ids="5103">flumazenil</z:chebi> administration in this and a previous case report, we would recommend a trial dose of 0.2 mg for cases of global postoperative <z:e sem="disease" ids="C0002622" disease_type="Mental or Behavioral Dysfunction" abbrv="">amnesia</z:e>, repeated if the first dose seems effective </plain></SENT>
</text></document>